IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ridgeback Capital Investments L.P.

Q4 2018 Holdings

Filed 2019-02-14 | 1 holdings | $37.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karyopharm Therapeutics Inc.(KPTIEUR)COM48576U106$37.0K3,945,200100.0%